DrugDashboards

Olmesartan Medoxomil And Hydrochlorothiazide

Olmesartan Medoxomil And Hydrochlorothiazide · OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1 · Tablet, Film Coated · Oral · Ascend Laboratories, LLC

NDC 67877-0452-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →

The short version

11 companies supply this market — deep enough that no single failure threatens the supply. The price has held steady around $0.2393 per unit over the past year. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.2393per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Medicaid generic ceiling (FUL)$0.2393per TABweighted avg manufacturer price $0.0856 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Jul 2025Sep 2026$0.2393
15 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$7.18
#90 count
$21.54

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$3,994
224 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for olmesartan medoxomil and hydrochlorothiazide (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · price up 4% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Regulatory

Application
ANDA207037
TE code
AB
Approval date
Jul 11, 2024
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olmesartan Medoxomil And Hydrochlorothiazide (Tablet, Film Coated)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 20, 2026Sep 3, 2026
Aurobindo Pharma LimitedOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 20, 2026Sep 3, 2026
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Accord Healthcare Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Accord Healthcare Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Accord Healthcare Inc.OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Ascend Laboratories, LLCOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Camber Pharmaceuticals, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
NorthStar RxLLCOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
Remedyrepack Inc.OLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
ScieGen Pharmaceuticals IncOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
ScieGen Pharmaceuticals IncOLMESARTAN MEDOXOMIL 20 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Sep 2, 2026
ScieGen Pharmaceuticals IncOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 25 mg/1Aug 26, 2026Sep 2, 2026
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Aug 31, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 26, 2026Aug 31, 2026
Aurobindo Pharma LimitedOLMESARTAN MEDOXOMIL 40 mg/1; HYDROCHLOROTHIAZIDE 12.5 mg/1Aug 20, 2026Aug 28, 2026
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 22, 2026
A-S Medication SolutionsOLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1Jul 22, 2026Aug 22, 2026
Bryant Ranch PrepackOLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 22, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1Jul 25, 2026Aug 22, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 25, 2026Aug 22, 2026
Golden State Medical Supply, Inc.OLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 25, 2026Aug 22, 2026
Aurobindo Pharma LimitedOLMESARTAN MEDOXOMIL 12.5 mg/1; HYDROCHLOROTHIAZIDE 20 mg/1Jul 22, 2026Aug 20, 2026
Aurobindo Pharma LimitedOLMESARTAN MEDOXOMIL 25 mg/1; HYDROCHLOROTHIAZIDE 40 mg/1Jul 22, 2026Aug 20, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olmesartan Medoxomil And Hydrochlorothiazide — NDC 67877-0452-30," retrieved September 3, 2026, https://drugdashboards.com/drug/67877045230.

Free to cite with attribution — see how the data is put together.